Abstract
While prions share the ability to propagate strain information with nucleic acid-based pathogens, it is unclear how they mutate and acquire fitness in the absence of this informational component. Because prion diseases occur as epidemics, understanding this mechanism is of paramount importance for implementing control strategies to limit their spread and for evaluating their zoonotic potential. Here we review emerging evidence indicating how prion protein primary structures, in concert with PrPSc conformational compatibility, determine prion strain mutation.
Key words: prions, strains, mutation, chronic wasting disease, prion protein primary structure
Prion strain mutation has been reported following interspecies transmission, for example transmission of sheep scrapie to rodents.1 Such circumstances may result in novel strains with an expanded host range.2 Chronic wasting disease (CWD), a burgeoning epidemic of cervids, is of particular concern. The only recognized prion disease of wild animals, its unparalleled transmission efficiency exemplifies prion contagion and complicates strategies for its control. Originally described in captive mule deer (Odocoileus hemionus hemionus) in northern Colorado in 19783 and subsequently in free-ranging mule deer and Rocky Mountain elk (Cervus elaphus nelsoni) in southeastern Wyoming and northeastern Colorado, CWD is emergent in wild and/or farm-raised cervids from 15 states and two provinces in North America. A retrospective assessment also revealed CWD infection of mule deer and black-tailed deer (Odocoileus hemonius columbianus) resident at the Toronto Zoo between 1973 and 2003.4 Outbreaks have also occurred in South Korea as a result of importation of sub-clinically infected animals.5,6 In addition to its increased geographic spread, the known host-range of CWD is also expanding. Since 2002, CWD has emerged in free-ranging populations of white-tailed deer (Odocoileus virginianus) east of the Mississippi.7 Most recently CWD has occurred in wild8 and captive moose (Alces alces shirasi)9 and has been transmitted to European red deer (Cervus elaphus elaphus).10 Whether the host range of CWD extends beyond the family Cervidae is currently unclear.
While it is now clear to most investigators that prions encipher strain information in the conformation of PrPSc,11–16 the existence and mutability of strains persuaded early researchers that prion diseases were caused by viruses, albeit ones with unconventional properties. The initial framework for understanding prion strains derived from studies of rodent-adapted sheep scrapie isolates, which led to standard criteria for characterizing and differentiating strains, including differences in the distribution and severity of PrP-associated pathology, often revealed by staining brain sections with anti-PrP antibodies17 and the time to onset of disease after inoculation, referred to as the incubation time.18,19 Using consistent doses and routes of inoculation, these studies demonstrated the remarkably consistent replication of strains, reflected in incubation times with standard errors generally <2% of the mean when serially passaged in mice of defined genotype.20 Subsequent studies revealed Prnp as the most important host factor controlling incubation time.21
By varying transmission conditions, these early studies also identified three classes of strains with varying stabilities.19 While the properties of class I strains are stable across genotypes, class II strains are stable when passaged in the Prnp genotype in which they were isolated, but gradually change during serial passage in another genotype until achieving a new set of stable properties. Class III strains are stable when passaged at high dilutions, otherwise strain properties break down, giving rise to new properties. While mutational events in agent-associated nucleic acid were originally cited as the cause of strain instability,1 more recently, changes in the conformation of PrPSc were shown to be associated with the acquisition of new strain properties.15 To account for the phenomena of prion transmission barriers, strain instability, heterogeneity and adaptation in the context of PrPSc conformation, the conformational selection model postulates that only a subset of PrPSc conformations is compatible with each individual PrP primary structure.22,23
While strain diversity is well documented for sheep scrapie, BSE, transmissible mink encephalopathy (TME) and human prions, until recently the prevalence of cervid prion strains had not been assessed. Prototype transgenic (Tg) mice expressing deer PrP, designated Tg(CerPrP)1536+/-24, recapitulated the cardinal neuropathological, clinical and biochemical features of CWD, an observation subsequently confirmed in comparable Tg mouse models.25–30 Although our original studies24 and subsequent work26,31 raised the possibility of CWD strain variation, the limited number of isolates and the lack of detailed strain analyses in those studies meant that this hypothesis remained speculative. Subsequent studies supported the feasibility of using Tg(CerPrP)1536+/- mice for characterizing naturally occurring CWD strains, CWD prions generated by protein misfolding cyclic amplification (PMCA) and novel cervid prions.32 Our comparative studies of CWD in Tg mice expressing deer and elk PrP30 also identified residue 226, the sole primary structural difference between deer and elk PrP, as a major determinant of CWD pathogenesis.
In a recent study, we used Tg(CerPrP) mice to determine the prevalence of CWD prion strains in a greatly expanded collection of captive and wild cervids from different species and geographic locations and to further assess the role of residue 226 on CWD pathogeneis.33 Our findings represent the first substantial evidence for two prevalent CWD prion strains. When ∼30 CWD isolates were transmitted to Tg(CerPrP) mice, two distinct neuro-pathological patterns were identified. When grouped together, mice with these distinct neuropathologies were associated with different mean incubation times, allowing us to classify mice as having been affected by one of two strains, referred to as CWD1 and CWD2. Patterns of neuropathological lesions produced in prion diseases are generally symmetrical in coronal sections of affected animals and humans, and this was a feature of the CWD1 strain. The unusual asymmetrical distribution of CerPrPSc and pathology in the inoculated hemisphere of mice infected by the CWD2 strain was therefore unexpected, but not unprecedented, since it is also a characteristic of certain scrapie strains such as 87A.34
Remarkably, primary transmissions of CWD prions from elk produced either CWD1 or CWD2 profiles, while transmission of deer inocula favored the production of mixed intra-study incubation times and CWD1 and CWD2 neuropathologies. From this we concluded that elk were infected with either CWD1 or CWD2, while deer brains harbored CWD1/CWD2 strain mixtures. In accordance with these findings, limited transmissions of PMCA-generated elk and deer prions produced only the CWD2 strain and mixed CWD1 and CWD2 responses respectively.
The different primary structures of deer and elk provides a framework for understanding these strain profiles and the hypothesis that CWD strain mutation is governed by the relative stabilities of prion propagation by elk and deer PrP primary structures. Thus, propagation of either strain by CerPrPC-Q226 in deer brain is unstable, and both strains are manifest as mixtures; the almost exclusive manifestation of CWD1 or CWD2 strains following primary transmissions of elk CWD prions reflects relatively stable strain propagation by CerPrPC-E226 in elk. Supporting this interpretation, serial passage of prions in the brains of diseased Tg(CerPrP)1536+/- mice produced strain mixtures, regardless of whether those prions originated in diseased elk or deer. Mutation of CWD1 and CWD2 propagated by CerPrPC-Q226 is reminiscent of unstable (Class III) scrapie strains such as 87A, and its more stable counterpart, ME7,1 but with CWD1 and CWD2 representing a novel strain class, with neither being a more stable derivative of the other. Because of the role played by residue 226, the description of a lysine polymorphism at this position in deer35 and its possible role on strain stability may be significant.
These structural considerations are of additional importance since they contribute to emerging evidence that the C-terminal domain, in concert with the loop region between beta2 and alpha helix 2, plays an important role in prion replication. Polymorphic variation resulting in replacement of phenylalanine for serine in mule deer PrP at residue 225, adjacent to the PrP variation in elk and deer, appears to be protective for the development of CWD.36 Residue 226 (222 in mice) was previously implicated in the binding of the hypothetical protein X to PrP.37,38 Recent structural studies indicating that alpha helix 3 in the C-terminal region affects structural stability of the loop region,39 support previous findings in Tg mice the suggesting the existence of a discontinuous epitope controlling prion propagation.40 This long-range interaction is of further interest in light of evidence that rigid or flexible loop structures dictated by amino acid substitutions in loop at MoPrP residues 170 and 174, control interspecies prion transmission.41
Given the distinct biological properties of CWD1 and CWD2, and the aforementioned proposal that strain characteristics are enciphered in the conformation of PrPSc,11,13–16 assessing the properties of CerPrPSc associated with each strain was of considerable interest. The electrophoretic migration patterns of CerPrPSc from the brains of mice infected by either strain were indiscernible. CerPrPSc associated with CWD1 and CWD2 was composed of equivalent proportions of di-, mono- and a-glycosyl forms and CerPrPSc from CWD1- and CWD2-infected mice had similar unfolding characteristics following treatment with guanidinium hydrochloride. The indistinguishable CerPrPSc conformations and unstable strain transitions of CWD1 and CWD2 in deer and Tg(CerPrP)1536+/- mice are consistent with their separation by relatively low energy barriers. Our inability to resolve subtle biochemical properties of CerPrPSc is reminiscent of the properties of postulated mutant substrains.42 While certain strains are associated with distinct conformers of PrPSc,11,13,32,43,44 not all strains that can be differentiated by biological means have readily recognizable differences in PrPSc.42,44,45 However, assuming the general protein-only hypothesis is correct, biochemical differences in PrPSc must exist. A precondition to resolving their physico-chemical differences of CWD1 and CWD2 is to establish conditions for their stable propagation. We are currently testing the hypothesis that Tg mice expressing elk PrP stably propagate either strain. While strain cloning could be accomplished by re-isolation of CWD1 or CWD2 at the end point of bioassays, biological cloning of cervid prion strains might also be facilitated by our recently described cell culture approaches for studying cervid prions.46 CWD1 and CWD2 strains purified by these means may differ with respect to protease-sensitive disease associated PrP (sPrPSc) or may be distinguished using more sensitive approaches, including Conformational Dependent Immunoassay,47 Fourier Transform Infrared spectroscopy (FT-IR)48–50 or luminescent conjugated polymers.51
When two prion strains infect a single host, one strain can interfere with the ability of the other to cause disease. It is unknown whether CWD1 and CWD2 interfere or act synergistically, or whether their co-existence contributes to the unparalleled efficiency of CWD transmission. Interestingly, transmission results reported in previous studies suggested that cervid brain inocula might be composed of strain mixtures.27,31 Additional previous studies also support our characterization of CWD1 and CWD2 strains. CWD has also been transmitted, albeit with varying efficiency, to Tg mice expressing mouse PrP.27,52 In the former study, a single mule deer isolate produced disease in all inoculated Tga20 mice. On successive passages, incubation times dropped to ∼160 d. In the second study, one elk isolate from a total of eight deer and elk CWD isolates induced disease in 75% of inoculated Tg4053 mice. It is worth noting that the distribution of lesions in both studies appeared to resemble the CWD1 pattern. Low efficiency CWD prion transmission was also recorded in hamsters and Tg mice expressing Syrian hamster PrP.31 In that study, during serial passage of mule deer CWD, fast and slow incubation time strains with different patterns of brain pathology and PrPSc deposition were also isolated.
Finally, our identification and characterization of distinct CWD strains and the influence of PrP primary structure on their stabilities, is of importance when considering the potential for transmission to species outside the family Cervidae. The appearance of variant Creutzfeldt-Jakob disease (vCJD) following human exposure to bovine spongiform encephalopathy (BSE),53,54 our demonstration of CWD prions in muscle55 and antler velvet,30 as well as Race and colleagues' description of CWD prions in deer fat,56 place the human species barrier to CWD at the forefront of public health concerns. North American hunters harvest thousands of deer and elk each year. Since it is not currently mandatory to have these animals tested for CWD, it is likely that humans consume CWD prions. While CWD prions have hitherto reassuringly failed to induce disease in Tg mice expressing human PrP,27,28,57 systematically addressing the zoonotic potential, as well as the tissue distributions of CWD1 and CWD2 strains in infected deer and elk, would nonetheless appear to be high priorities.
Footnotes
Previously published online:www.landesbioscience.com/journals/prion/article/13675
References
- 1.Bruce ME, Dickinson AG. Biological evidence that the scrapie agent has an independent genome. J Gen Virol. 1987;68:79–89. doi: 10.1099/0022-1317-68-1-79. [DOI] [PubMed] [Google Scholar]
- 2.Bartz JC, Marsh RF, McKenzie DI, Aiken JM. The host range of chronic wasting disease is altered on passage in ferrets. Virology. 1998;251:297–301. doi: 10.1006/viro.1998.9427. [DOI] [PubMed] [Google Scholar]
- 3.Williams ES, Young S. Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J Wildl Dis. 1980;16:89–98. doi: 10.7589/0090-3558-16.1.89. [DOI] [PubMed] [Google Scholar]
- 4.Dube C, Mehren KG, Barker IK, Peart BL, Balachandran A. Retrospective investigation of chronic wasting disease of cervids at the Toronto Zoo 1973–2003. Canadian Vet J. 2006;47:1185–1193. [PMC free article] [PubMed] [Google Scholar]
- 5.Sohn HJ, Kim JH, Choi KS, Nah JJ, Joo YS, Jean YH, et al. A case of chronic wasting disease in an elk imported to Korea from Canada. J Vet Med Sci. 2002;64:855–858. doi: 10.1292/jvms.64.855. [DOI] [PubMed] [Google Scholar]
- 6.Kim TY, Shon HJ, Joo YS, Mun UK, Kang KS, Lee YS. Additional cases of Chronic Wasting Disease in imported deer in Korea. J Vet Med Sci. 2005;67:753–759. doi: 10.1292/jvms.67.753. [DOI] [PubMed] [Google Scholar]
- 7.Joly DO, Ribic CA, Langenberg JA, Beheler K, Batha CA, Dhuey BJ, et al. Chronic wasting disease in free-ranging Wisconsin White-tailed Deer. Emerg Infect Dis. 2003;9:599–601. doi: 10.3201/eid0905.020721. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Baeten LA, Powers BE, Jewell JE, Spraker TR, Miller MW. A natural case of chronic wasting disease in a free-ranging moose (Alces alces shirasi) J Wildl Dis. 2007;43:309–314. doi: 10.7589/0090-3558-43.2.309. [DOI] [PubMed] [Google Scholar]
- 9.Kreeger TJ, Montgomery DL, Jewell JE, Schultz W, Williams ES. Oral transmission of chronic wasting disease in captive Shira's moose. J Wildl Dis. 2006;42:640–645. doi: 10.7589/0090-3558-42.3.640. [DOI] [PubMed] [Google Scholar]
- 10.Martin S, Jeffrey M, Gonzalez L, Siso S, Reid HW, Steele P, et al. Immunohistochemical and biochemical characteristics of BSE and CWD in experimentally infected European red deer (Cervus elaphus elaphus) BMC Vet Res. 2009;5:26. doi: 10.1186/1746-6148-5-26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bessen RA, Marsh RF. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol. 1994;68:7859–7868. doi: 10.1128/jvi.68.12.7859-7868.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT, Caughey B. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature. 1995;375:698–700. doi: 10.1038/375698a0. [DOI] [PubMed] [Google Scholar]
- 13.Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science. 1996;274:2079–2082. doi: 10.1126/science.274.5295.2079. [DOI] [PubMed] [Google Scholar]
- 14.Korth C, Kaneko K, Groth D, Heye N, Telling G, Mastrianni J, et al. Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci USA. 2003;100:4784–4789. doi: 10.1073/pnas.2627989100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Peretz D, Williamson RA, Legname G, Matsunaga Y, Vergara J, Burton DR, et al. A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron. 2002;34:921–932. doi: 10.1016/s0896-6273(02)00726-2. [DOI] [PubMed] [Google Scholar]
- 16.Scott MR, Peretz D, Nguyen HO, Dearmond SJ, Prusiner SB. Transmission barriers for bovine, ovine and human prions in transgenic mice. J Virol. 2005;79:5259–5271. doi: 10.1128/JVI.79.9.5259-5271.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Bruce ME, McBride PA, Farquhar CF. Precise targeting of the pathology of the sialoglycoprotein, PrP and vacuolar degeneration in mouse scrapie. Neurosci Lett. 1989;102:1–6. doi: 10.1016/0304-3940(89)90298-x. [DOI] [PubMed] [Google Scholar]
- 18.Dickinson AG, Meikle VMH. Host-genotype and agent effects in scrapie incubation: change in allelic interaction with different strains of agent. Mol Gen Genet. 1971;112:73–79. doi: 10.1007/BF00266934. [DOI] [PubMed] [Google Scholar]
- 19.Bruce ME, Dickinson AG. Biological stability of different classes of scrapie agent. In: Prusiner SB, Hadlow WJ, editors. Slow Transmissible Diseases of the Nervous System. Vol. 2. New York: Academic Press; 1979. pp. 71–86. [Google Scholar]
- 20.Bruce ME. Scrapie strain variation and mutation. Brit Med Bul. 1993;49:822–838. doi: 10.1093/oxfordjournals.bmb.a072649. [DOI] [PubMed] [Google Scholar]
- 21.Westaway D, Goodman PA, Mirenda CA, McKinley MP, Carlson GA, Prusiner SB. Distinct prion proteins in short and long scrapie incubation period mice. Cell. 1987;51:651–662. doi: 10.1016/0092-8674(87)90134-6. [DOI] [PubMed] [Google Scholar]
- 22.Collinge J. Variant Creutzfeldt-Jakob disease. Lancet. 1999;354:317–323. doi: 10.1016/S0140-6736(99)05128-4. [DOI] [PubMed] [Google Scholar]
- 23.Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science. 2007;318:930–936. doi: 10.1126/science.1138718. [DOI] [PubMed] [Google Scholar]
- 24.Browning SR, Mason GL, Seward T, Green M, Eliason GA, Mathiason C, et al. Transmission of prions from mule deer and elk with chronic wasting disease to transgenic mice expressing cervid PrP. J Virol. 2004;78:13345–13350. doi: 10.1128/JVI.78.23.13345-13350.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Meade-White K, Race B, Trifilo M, Bossers A, Favara C, Lacasse R, et al. Resistance to chronic wasting disease in transgenic mice expressing a naturally occurring allelic variant of deer prion protein. J Virol. 2007;81:4533–4539. doi: 10.1128/JVI.02762-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.LaFauci G, Carp RI, Meeker HC, Ye X, Kim JI, Natelli M, et al. Passage of chronic wasting disease prion into transgenic mice expressing Rocky Mountain elk (Cervus elaphus nelsoni) PrPC. J Gen Virol. 2006;87:3773–3780. doi: 10.1099/vir.0.82137-0. [DOI] [PubMed] [Google Scholar]
- 27.Tamguney G, Giles K, Bouzamondo-Bernstein E, Bosque PJ, Miller MW, Safar J, et al. Transmission of elk and deer prions to transgenic mice. J Virol. 2006;80:9104–9114. doi: 10.1128/JVI.00098-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Kong Q, Huang S, Zou W, Vanegas D, Wang M, Wu D, et al. Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J Neurosci. 2005;25:7944–7949. doi: 10.1523/JNEUROSCI.2467-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Trifilo MJ, Ying G, Teng C, Oldstone MB. Chronic wasting disease of deer and elk in transgenic mice: Oral transmission and pathobiology. Virology. 2007 doi: 10.1016/j.virol.2007.03.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Angers RC, Seward TS, Napier D, Green M, Hoover EA, Spraker T, et al. Chronic wasting disease prions in elk antler velvet. Emerg Infect Dis. 2009;15:696–703. doi: 10.3201/eid1505.081458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Raymond GJ, Raymond LD, Meade-White KD, Hughson AG, Favara C, Gardner D, et al. Transmission and adaptation of chronic wasting disease to hamsters and transgenic mice: evidence for strains. J Virol. 2007;81:4305–4314. doi: 10.1128/JVI.02474-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Green KM, Castilla J, Seward TS, Napier DL, Jewell JE, Soto C, et al. Accelerated high fidelity prion amplification within and across prion species barriers. PLoS Pathog. 2008;4:1000139. doi: 10.1371/journal.ppat.1000139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Angers RC, Kang HE, Napier D, Browning S, Seward T, Mathiason C, et al. Prion strain mutation determined by prion protein conformational compatibility and primary structure. Science. 2010;328:1154–1158. doi: 10.1126/science.1187107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Bruce ME, Fraser H. Focal and asymmetrical vacuolar lesions in the brains of mice infected with certain strains of scrapie. Acta Neuropath. 1982;58:133–140. doi: 10.1007/BF00691654. [DOI] [PubMed] [Google Scholar]
- 35.Johnson C, Johnson J, Vanderloo JP, Keane D, Aiken JM, McKenzie D. Prion protein polymorphisms in white-tailed deer influence susceptibility to chronic wasting disease. J Gen Virol. 2006;87:2109–2114. doi: 10.1099/vir.0.81615-0. [DOI] [PubMed] [Google Scholar]
- 36.Jewell JE, Conner MM, Wolfe LL, Miller MW, Williams ES. Low frequency of PrP genotype 225SF among free-ranging mule deer (Odocoileus hemionus) with chronic wasting disease. J Gen Virol. 2005;86:2127–2134. doi: 10.1099/vir.0.81077-0. [DOI] [PubMed] [Google Scholar]
- 37.Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE, et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell. 1995;83:79–90. doi: 10.1016/0092-8674(95)90236-8. [DOI] [PubMed] [Google Scholar]
- 38.Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL, et al. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci USA. 1997;94:10069–10074. doi: 10.1073/pnas.94.19.10069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Christen B, Hornemann S, Damberger FF, Wuthrich K. Prion protein NMR structure from tammar wallaby (Macropus eugenii) shows that the beta2-alpha2 loop is modulated by long-range sequence effects. J Mol Biol. 2009;389:833–845. doi: 10.1016/j.jmb.2009.04.040. [DOI] [PubMed] [Google Scholar]
- 40.Scott MR, Safar J, Telling G, Nguyen O, Groth D, Torchia M, et al. Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice. Proc Natl Acad Sci USA. 1997;94:14279–14284. doi: 10.1073/pnas.94.26.14279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Sigurdson CJ, Nilsson KP, Hornemann S, Manco G, Fernandez-Borges N, Schwarz P, et al. A molecular switch controls interspecies prion disease transmission in mice. J Clin Invest. 2010;120:2590–2599. doi: 10.1172/JCI42051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Li J, Browning S, Mahal SP, Oelschlegel AM, Weissmann C. Darwinian evolution of prions in cell culture. Science. 2010;327:869–872. doi: 10.1126/science.1183218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of “new variant” CJD. Nature. 1996;383:685–690. doi: 10.1038/383685a0. [DOI] [PubMed] [Google Scholar]
- 44.Peretz D, Scott MR, Groth D, Williamson RA, Burton DR, Cohen FE, et al. Strain-specified relative conformational stability of the scrapie prion protein. Prot Sci. 2001;10:854–863. doi: 10.1110/ps.39201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Legname G, Nguyen HO, Peretz D, Cohen FE, DeArmond SJ, Prusiner SB. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci USA. 2006;103:19105–19110. doi: 10.1073/pnas.0608970103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Bian J, Napier D, Khaychuck V, Angers R, Graham C, Telling G. Cell-based quantification of chronic wasting disease prions. J Virol. 2010;84:8322–8326. doi: 10.1128/JVI.00633-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, et al. Eight prion strains have PrPSc molecules with different conformations. Nat Med. 1998;4:1157–1165. doi: 10.1038/2654. [DOI] [PubMed] [Google Scholar]
- 48.Caughey B, Raymond GJ, Bessen RA. Strain-dependent differences in b-sheet conformations of abnormal prion protein. J Biol Chem. 1998;273:32230–32235. doi: 10.1074/jbc.273.48.32230. [DOI] [PubMed] [Google Scholar]
- 49.Thomzig A, Spassov S, Friedrich M, Naumann D, Beekes M. Discriminating scrapie and bovine spongiform encephalopathy isolates by infrared spectroscopy of pathological prion protein. J Biol Chem. 2004;279:33847–33854. doi: 10.1074/jbc.M403730200. [DOI] [PubMed] [Google Scholar]
- 50.Spassov S, Beekes M, Naumann D. Structural differences between TSEs strains investigated by FT-IR spectroscopy. Biochim Biophys Acta. 2006;1760:1138–1149. doi: 10.1016/j.bbagen.2006.02.018. [DOI] [PubMed] [Google Scholar]
- 51.Sigurdson CJ, Nilsson KP, Hornemann S, Manco G, Polymenidou M, Schwarz P, et al. Prion strain discrimination using luminescent conjugated polymers. Nat Methods. 2007;4:1023–1030. doi: 10.1038/nmeth1131. [DOI] [PubMed] [Google Scholar]
- 52.Sigurdson CJ, Manco G, Schwarz P, Liberski P, Hoover EA, Hornemann S, et al. Strain fidelity of chronic wasting disease upon murine adaptation. J Virol. 2006;80:12303–12311. doi: 10.1128/JVI.01120-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, et al. Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature. 1997;389:498–501. doi: 10.1038/39057. [DOI] [PubMed] [Google Scholar]
- 54.Hill AF, Desbruslais M, Joiner S, Sidle KCL, Gowland I, Collinge J, et al. The same prion strain causes vCJD and BSE. Nature. 1997;389:448–450. doi: 10.1038/38925. [DOI] [PubMed] [Google Scholar]
- 55.Angers RC, Browning SR, Seward TS, Sigurdson CJ, Miller MW, Hoover EA, et al. Prions in skeletal muscles of deer with chronic wasting disease. Science. 2006;311:1117. doi: 10.1126/science.1122864. [DOI] [PubMed] [Google Scholar]
- 56.Race B, Meade-White K, Race R, Chesebro B. Prion infectivity in fat of deer with chronic wasting disease. J Virol. 2009;83:9608–9610. doi: 10.1128/JVI.01127-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Sandberg M, Al-Doujaily H, Sigurdson C, Glatzel M, Oapos;Malley C, Powell C, et al. Chronic wasting disease prions are not transmissible to transgenic mice overexpressing human prion protein. J Gen Virol. 2010 doi: 10.1099/vir.0.024380-0. [DOI] [PMC free article] [PubMed] [Google Scholar]